Development of a Single Dose, Multicomponent, Thermostable Vaccine
Using thermostable nanoparticles as a delivery mechanism, Yasmin Thanavala of Health Research Inc and Roswell Park Cancer Institute in the U.S. will work to develop a single dose vaccine that can be given as close to birth as possible to protect against multiple diseases.